Skip to Main Content

Paper Details

High-risk neuroblastoma with NF1 loss of function is targetable using SHP2 inhibition.
Cell Rep
10
2022
ERK, GAP, GTPase activation protein, High, High-risk, MAPK, MEK, MYCN, NB, NB tumors, NB) tumors, NF1, RAF, RAS, SHP099, SHP2, mitogen-activated protein kinase, mouse, neuroblastoma, neuroblastoma (, neurofibromin 1, tumor, tumor-derived cell lines
Author NameAffiliation
Mikhail G DozmorovVirginia Commonwealth University
Giordano CaponigroNovartis Institute for Biological Research
Cyril H BenesCenter for Cancer Research, Massachusetts General Hospital, Harvard Medical School
  • 1 - 3

Datasets

Release 1.2